|
APPL2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.033600E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.430600E-01 |
| Normal-vs-Stage2 |
1.361350E-01 |
| Normal-vs-Stage3 |
1.89559999996813E-06 |
| Normal-vs-Stage4 |
1.629140E-04 |
| Stage1-vs-Stage2 |
3.616400E-01 |
| Stage1-vs-Stage3 |
2.813300E-04 |
| Stage1-vs-Stage4 |
4.803000E-03 |
| Stage2-vs-Stage3 |
8.534300E-02 |
| Stage2-vs-Stage4 |
1.762370E-01 |
| Stage3-vs-Stage4 |
7.368600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.833400E-04 |
| Normal-vs-AfricanAmerican |
5.280200E-01 |
| Normal-vs-Asian |
5.998000E-01 |
| Caucasian-vs-AfricanAmerican |
3.356000E-01 |
| Caucasian-vs-Asian |
1.474220E-01 |
| AfricanAmerican-vs-Asian |
4.649800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.99430000000067E-05 |
| Normal-vs-Female |
2.575600E-01 |
| Male-vs-Female |
1.843550E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.082050E-01 |
| Normal-vs-Age(41-60Yrs) |
3.130100E-02 |
| Normal-vs-Age(61-80Yrs) |
2.380600E-03 |
| Normal-vs-Age(81-100Yrs) |
1.206050E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.876600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.234200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.746600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.591400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.068600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.981800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.095400E-01 |
| Normal-vs-Grade 2 |
2.509600E-01 |
| Normal-vs-Grade 3 |
1.101560E-03 |
| Normal-vs-Grade 4 |
2.3057999953835E-08 |
| Grade 1-vs-Grade 2 |
1.397450E-01 |
| Grade 1-vs-Grade 3 |
5.868000E-02 |
| Grade 1-vs-Grade 4 |
1.139900E-02 |
| Grade 2-vs-Grade 3 |
3.644100E-02 |
| Grade 2-vs-Grade 4 |
1.90284000000096E-05 |
| Grade 3-vs-Grade 4 |
6.738200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.547800E-01 |
| Normal-vs-ccB subtype |
4.3139000005521E-07 |
| ccA subtype-vs-ccB subtype |
1.94990000035311E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.462330E-02 |
| Normal-vs-N1 |
1.379020E-01 |
| N0-vs-N1 |
4.482400E-01 |
|
|
